Experience | Leaflets | Support | Patient+ | Weblinks | News | Products | Other
This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Managing Impaired Glucose Tolerance in Primary Care
Post your experienceSee others (2 there)
|
Studies in the United Kingdom have reported the prevalence of impaired glucose tolerance in the 35-65 year age group to be about 17%.4
Risk factors
- Obesity
- First-degree relative with diabetes
- Certain ethnic groups, e.g. Asian, Afro-Caribbean5
- Hypertension6
- Patients with impaired glucose tolerance are usually asymptomatic.
- Features of related risk factors for cardiovascular disease may be present, even with a mild degree of hyperglycemia. They include hypertension, obesity, dyslipidaemia, and macrovascular disease, such as stroke, coronary disease or peripheral vascular disease.
Oral glucose tolerance test:
- Overnight fast of 8-14 hours; only water may be drunk. Smoking should also be avoided during this time.
- Adults: drink 75 g anhydrous glucose dissolved in 250-300 ml water over 5 minutes. For children, the glucose load is 1.75 g per kg body weight.
- Blood glucose is measured before the drink and after 30, 60, 90 and 120 minutes.
- Several cardiovascular findings are more prevalent, including hypertension, raised serum cholesterol, angina, abnormal heart findings and medical history of arteriosclerosis and stroke.7
- Impaired fasting glycaemia is defined as a fasting plasma glucose of 6.1 mmol/l or greater but less than 7.0 mmol/l. There is an increased risk of development of diabetes but less evidence of an associated risk of cardiovascular disease.
- Increasing evidence indicates that intervention can favourably influence the clinical course of impaired glucose tolerance, with some studies showing a 58% reduction in progression to diabetes.8
- The metabolic syndrome (defined by impaired fasting glucose, large waist circumference, and high triglycerides) efficiently identifies subjects likely to have impaired glucose tolerance on oral glucose tolerance test, and thus be appropriate for diabetes prevention interventions.9
- Annual screening of people with impaired glucose tolerance by fasting blood glucose is currently recommended.
General measures
- It has been shown that the risk of progression from impaired glucose tolerance to type 2 diabetes mellitus can be reduced by lifestyle interventions.10
- The advice is essentially the same as diet and exercise advice in diabetes:
- Weight reduction, if appropriate
- Reduction in total intake of fat and intake of saturated fat
- Increasing intake of dietary fibre
- Increasing physical activity
Pharmacological
- Reversal of drug-related iatrogenic causation of glucose intolerance. Whenever possible, substitute agent(s) that do not have an adverse effect on glucose tolerance, or reduce the dosage of the offending drug, e.g. replacing a thiazide diuretic when treating hypertension, minimising use of corticosteroids.
- Several clinical trials have found that lifestyle modification is the most effective strategy to prevent progression to type 2 diabetes.11 Both metformin and acarbose have been demonstrated to decrease the development of type 2 diabetes.
- Ongoing clinical trials are evaluating other agents, including ACE inhibitors, angiotensin receptor antagonists and thiazolidinediones, to prevent both type 2 diabetes and cardiovascular events. In combination with lifestyle modification, these therapies may provide effective prevention of type 2 diabetes and its consequences in high-risk patients.12
- There has been some showing that ACE inhibitors may have a role in preventing diabetes in individuals with high cardiovascular risk factors.13 There may also be a preventative role for rosiglitazone.14
- 20-50% of people with impaired glucose tolerance will progress to type 2 diabetes within 10 years of diagnosis.15
- In addition, people with impaired glucose tolerance are known to be at significantly increased risk of cardiovascular disease, which may present before the onset of diabetes. Rates of cardiovascular risk factors are intermediate between those with normal glucose tolerance and those with diabetes. Impaired fasting glycaemia has not been shown to be a risk factor for cardiovascular disease.16
- Baseline plasma glucose is the most consistent predictor of progression to diabetes.
- Impaired glucose tolerance has not been clearly associated with microvascular complications e.g. nephropathy, retinopathy or neuropathy.
- Avoid being overweight and eat a healthy diet, with high fibre, low fat and lots of fruit and vegetables.
- Encourage regular physical activity.
- Avoid alcohol abuse.
Document references
- WHO; World Health Organisation/International Diabetes Federation, Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia, 2006.
- Zavaroni I, Dall'Aglio E, Bonora E, et al; Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance. Am J Med. 1987 Oct;83(4):609-12. [abstract]
- No authors listed, JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart. 2005 Dec;91 Suppl 5:v1-52.
- Davies MJ, Gray IP; Impaired glucose tolerance. BMJ. 1996 Feb 3;312(7026):264-5.
- Whincup PH, Gilg JA, Papacosta O, et al; Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ. 2002 Mar 16;324(7338):635. [abstract]
- No authors listed; Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002 Nov;40(5):679-86. [abstract]
- Harris MI; Impaired glucose tolerance in the U.S. population. Diabetes Care. 1989 Jul-Aug;12(7):464-74. [abstract]
- Tuomilehto J, Lindstrom J, Eriksson JG, et al; Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 May 3;344(18):1343-50. [abstract]
- Meigs JB, Williams K, Sullivan LM, et al; Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care. 2004 Jun;27(6):1417-26. [abstract]
- Mensink M, Blaak EE, Corpeleijn E, et al; Lifestyle intervention according to general recommendations improves glucose tolerance. Obes Res. 2003 Dec;11(12):1588-96. [abstract]
- Ratner R, Goldberg R, Haffner S, et al; Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care. 2005 Apr;28(4):888-94. [abstract]
- Petersen JL, McGuire DK; Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management. Diab Vasc Dis Res. 2005 Feb;2(1):9-15. [abstract]
- Yusuf S, Gerstein H, Hoogwerf B, et al; Ramipril and the development of diabetes. JAMA. 2001 Oct 17;286(15):1882-5. [abstract]
- Gerstein HC, Yusuf S, Bosch J, et al; Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006 Sep 23;368(9541):1096-105. [abstract]
- Alberti KG; Impaired glucose tolerance: what are the clinical implications? Diabetes Res Clin Pract. 1998 Jul;40 Suppl:S3-8. [abstract]
- Tominaga M, Eguchi H, Manaka H, et al; Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 1999 Jun;22(6):920-4. [abstract]
Internet and further reading
- Olatunbosun ST, Dagogo-Jack S. Glucose Intolerance. e-Medicine. August 2008.
Document ID: 2430
Document Version: 21
Document Reference: bgp24557
Last Updated: 10 Aug 2009
Planned Review: 10 Aug 2011
The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest. Find out more about updating.
Patient UK Hearing Impairment Survey
Patient UK are grateful to the 550 people who took part in this survey.
To see the results click here.
If you'd like to leave your feedback, please go to our interactive forum.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicine
View Patient Experience for 'Impaired Glucose Tolerance' (2 there)Health Topic information leaflets related to this topic (^ top of page)
Blood Test - GlucoseSupport Groups related to this topic (^ top of page)
Royal College of General Practitioners
Royal College of General Practitioners ScotlandPatientPlus articles related to this topic (^ top of page)
Audit and Audit Cycle
Body Surface Area Calculator (Mosteller)
Community Care
Coping with Uncertainty in Primary Care
Diabetes Mellitus
Glucose Tolerance Tests
Keeping Up-to-date
Managing Epilepsy in Primary Care
Osteoporosis Management in Primary Care
Personal Development Plans
Prescribing Analysis and Audit
Primary Care Clinics
Primary Health Care Team
Reaccreditation - Current State of PlayLinks to other selected websites related to this topic (^ top of page)
Medical and Health NewsPatient UK Newspaper (^ top of page)
Recent related news items
NHS doctors top league table of extra payments
It's time to slay the bureaucratic monster that's ruining the NHS
Doctors 'should avoid treating family'
High danger of diabetes for 620,000 Scots
Half of deaf patients can't communicate with their GPAll news by related topic
Primary Care And General Practice news
Impaired Glucose Tolerance newsRelated Products (^ top of page)
Medical equipment
Health Monitors - Glucose
Books

Other - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
UK Guidelines
Online Videos
Medline
Other good health sites
Want to search some more? Use the Google Search box below to search our site.
Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.
Want to advertise on this site? Find out how >>
Here you can follow a link to view existing patient experiences on this subject, or to add your own
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Note: this will open in a new window
Note: this will open in a new window
Here you can follow a link to view existing patient experiences on this subject, or to add your own
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Note: this will open in a new window
Note: this will open in a new window




